Physician profile
Olivia Ball
NPI 1366887945
$2,165.33
in general payments reported to CMS, 2019-2025
43 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $182 · 2021: $62.38 · 2022: $426 · 2023: $570 · 2024: $434 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,153.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $376.62 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $129.17 | 2019-2023 | Calquence, Imfinzi |
| Merck Sharp & Dohme LLC | $126.88 | 2019-2023 | Keytruda, Lynparza |
| Amgen INC. | $123.04 | 2019-2022 | |
| Daiichi Sankyo INC. | $102.95 | 2020-2024 | Enhertu |
| Incyte Corporation | $102.70 | 2020-2024 | Jakafi, Monjuvi |
| Genentech USA, INC. | $77.62 | 2024 | Tecentriq, Alecensa, Phesgo |
| Lilly USA, LLC | $76.46 | 2020-2023 | Jaypirca, Verzenio |
| Janssen Biotech, INC. | $66.44 | 2023-2024 | Tecvayli, Darzalex, Talvey |
| Eisai INC. | $55.74 | 2022-2024 | |
| Ipsen Biopharmaceuticals, INC | $55.74 | 2021-2023 | Somatuline Depot, Onivyde |
| Pharmacyclics LLC, An Abbvie Company | $53.77 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $53.74 | 2019-2023 | Libtayo |
| Bayer Healthcare Pharmaceuticals INC. | $50.42 | 2019-2024 | |
| Alexion Pharmaceuticals, INC. | $45.04 | 2023-2024 | Ultomiris |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $42.78 | 2025 | Bioprotect Balloon Implant System |
| Teleflex LLC | $42.71 | 2024-2025 | Barrigel |
| Verastem, INC. | $35.77 | 2019 | |
| Sumitomo Pharma America, INC. | $35.22 | 2024-2025 | Orgovyx |
| Seagen INC. | $35.11 | 2023 | Padcev, Tukysa |
| Adc Therapeutics America, INC. | $34.51 | 2022-2023 | |
| Pfizer INC. | $33.35 | 2022-2023 | |
| Kyowa Kirin, INC. | $33.25 | 2019 | |
| Genzyme Corporation | $32.17 | 2022-2023 | |
| Morphosys, US INC. | $31.73 | 2023 | Monjuvi |
| Novocure INC. | $28.51 | 2020 | |
| Exelixis INC. | $28.38 | 2021-2023 | Cabometyx |
| Puma Biotechnology, INC. | $23.45 | 2019 | |
| Siemens Medical Solutions USA, INC. | $21.51 | 2023 | Varian Ethos Treatment Planning |
| Progenics Pharmaceuticals, INC. | $20.38 | 2023 | Pylarify |
| Genmab U.S., INC. | $18.50 | 2024 | Epkinly |
| Takeda Pharmaceuticals U.S.A., INC. | $18.18 | 2020 | |
| G1 Therapeutics, INC. | $18.16 | 2023 | Cosela |
| Secura Bio, INC. | $17.11 | 2020 | |
| Celgene Corporation | $14.89 | 2020 | |
| Apellis Pharmaceuticals, INC. | $14.52 | 2023 | Empaveli |
| Astellas Pharma US INC | $14.01 | 2023 | Xtandi |
| Sandoz INC. | $13.57 | 2025 | Jubbonti |
| Sobi, INC | $12.96 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.42 | 2021 | |
| Myriad Genetic Laboratories, INC. | $12.35 | 2022 | |
| Jazz Pharmaceuticals INC. | $12.24 | 2019 | |
| Veracyte, INC. | $11.26 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Ball listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.